ArticleHistory and philosophy of the life sciences2025
The Apgar score and race: why healthy babies are supposed to be "pink".
Article in History and philosophy of the life sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Outlining the Apgar Score's use throughout the latter half of the twentieth century, I propose that the historical abuse of this score for newborn wellness does not only come from the obviously white-centered assessment criteria for "color" established in the 1950s. The more concerning aspect of the Score is its potential interpretation as measuring one unitary construct which captures both the past asphyxiated condition and future health risks of individual infants (a problem that has been noted for decades in professional guidance documents). My novel contribution is to use the history of the Apgar Score's use and misuse to demonstrate why racial inequities in medicine pose a problem for two frameworks in philosophy of measurement when applied to patient outcome measures. I ultimately argue that the case of the Apgar Score shows how both dominant frameworks in philosophy of measurement, that of coordination (within the representational theory of measurement) and that of psychometric validity, fail to help us fully comprehend the challenge of clinical measuring with indices. Both frameworks expect that, at some point, the process of coordination or validation of an instrument will end. An expanded and historically-informed framework is warranted for understanding how patient outcome measures are validated (and re-validated) over time, which can include the social and institutional forces which render an index relevant, biased, or questionable for different aims.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.